Cargando…

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases

The accumulation of misfolded proteins in the human brain is one of the critical features of many neurodegenerative diseases, including Alzheimer's disease (AD). Assembles of beta-amyloid (Aβ) peptide—either soluble (oligomers) or insoluble (plaques) and of tau protein, which form neurofibrilla...

Descripción completa

Detalles Bibliográficos
Autores principales: Lackie, Rachel E., Maciejewski, Andrzej, Ostapchenko, Valeriy G., Marques-Lopes, Jose, Choy, Wing-Yiu, Duennwald, Martin L., Prado, Vania F., Prado, Marco A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433227/
https://www.ncbi.nlm.nih.gov/pubmed/28559789
http://dx.doi.org/10.3389/fnins.2017.00254
_version_ 1783236810293379072
author Lackie, Rachel E.
Maciejewski, Andrzej
Ostapchenko, Valeriy G.
Marques-Lopes, Jose
Choy, Wing-Yiu
Duennwald, Martin L.
Prado, Vania F.
Prado, Marco A. M.
author_facet Lackie, Rachel E.
Maciejewski, Andrzej
Ostapchenko, Valeriy G.
Marques-Lopes, Jose
Choy, Wing-Yiu
Duennwald, Martin L.
Prado, Vania F.
Prado, Marco A. M.
author_sort Lackie, Rachel E.
collection PubMed
description The accumulation of misfolded proteins in the human brain is one of the critical features of many neurodegenerative diseases, including Alzheimer's disease (AD). Assembles of beta-amyloid (Aβ) peptide—either soluble (oligomers) or insoluble (plaques) and of tau protein, which form neurofibrillary tangles, are the major hallmarks of AD. Chaperones and co-chaperones regulate protein folding and client maturation, but they also target misfolded or aggregated proteins for refolding or for degradation, mostly by the proteasome. They form an important line of defense against misfolded proteins and are part of the cellular quality control system. The heat shock protein (Hsp) family, particularly Hsp70 and Hsp90, plays a major part in this process and it is well-known to regulate protein misfolding in a variety of diseases, including tau levels and toxicity in AD. However, the role of Hsp90 in regulating protein misfolding is not yet fully understood. For example, knockdown of Hsp90 and its co-chaperones in a Caenorhabditis elegans model of Aβ misfolding leads to increased toxicity. On the other hand, the use of Hsp90 inhibitors in AD mouse models reduces Aβ toxicity, and normalizes synaptic function. Stress-inducible phosphoprotein 1 (STI1), an intracellular co-chaperone, mediates the transfer of clients from Hsp70 to Hsp90. Importantly, STI1 has been shown to regulate aggregation of amyloid-like proteins in yeast. In addition to its intracellular function, STI1 can be secreted by diverse cell types, including astrocytes and microglia and function as a neurotrophic ligand by triggering signaling via the cellular prion protein (PrP(C)). Extracellular STI1 can prevent Aβ toxic signaling by (i) interfering with Aβ binding to PrP(C) and (ii) triggering pro-survival signaling cascades. Interestingly, decreased levels of STI1 in C. elegans can also increase toxicity in an amyloid model. In this review, we will discuss the role of intracellular and extracellular STI1 and the Hsp70/Hsp90 chaperone network in mechanisms underlying protein misfolding in neurodegenerative diseases, with particular focus on AD.
format Online
Article
Text
id pubmed-5433227
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54332272017-05-30 The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases Lackie, Rachel E. Maciejewski, Andrzej Ostapchenko, Valeriy G. Marques-Lopes, Jose Choy, Wing-Yiu Duennwald, Martin L. Prado, Vania F. Prado, Marco A. M. Front Neurosci Neuroscience The accumulation of misfolded proteins in the human brain is one of the critical features of many neurodegenerative diseases, including Alzheimer's disease (AD). Assembles of beta-amyloid (Aβ) peptide—either soluble (oligomers) or insoluble (plaques) and of tau protein, which form neurofibrillary tangles, are the major hallmarks of AD. Chaperones and co-chaperones regulate protein folding and client maturation, but they also target misfolded or aggregated proteins for refolding or for degradation, mostly by the proteasome. They form an important line of defense against misfolded proteins and are part of the cellular quality control system. The heat shock protein (Hsp) family, particularly Hsp70 and Hsp90, plays a major part in this process and it is well-known to regulate protein misfolding in a variety of diseases, including tau levels and toxicity in AD. However, the role of Hsp90 in regulating protein misfolding is not yet fully understood. For example, knockdown of Hsp90 and its co-chaperones in a Caenorhabditis elegans model of Aβ misfolding leads to increased toxicity. On the other hand, the use of Hsp90 inhibitors in AD mouse models reduces Aβ toxicity, and normalizes synaptic function. Stress-inducible phosphoprotein 1 (STI1), an intracellular co-chaperone, mediates the transfer of clients from Hsp70 to Hsp90. Importantly, STI1 has been shown to regulate aggregation of amyloid-like proteins in yeast. In addition to its intracellular function, STI1 can be secreted by diverse cell types, including astrocytes and microglia and function as a neurotrophic ligand by triggering signaling via the cellular prion protein (PrP(C)). Extracellular STI1 can prevent Aβ toxic signaling by (i) interfering with Aβ binding to PrP(C) and (ii) triggering pro-survival signaling cascades. Interestingly, decreased levels of STI1 in C. elegans can also increase toxicity in an amyloid model. In this review, we will discuss the role of intracellular and extracellular STI1 and the Hsp70/Hsp90 chaperone network in mechanisms underlying protein misfolding in neurodegenerative diseases, with particular focus on AD. Frontiers Media S.A. 2017-05-16 /pmc/articles/PMC5433227/ /pubmed/28559789 http://dx.doi.org/10.3389/fnins.2017.00254 Text en Copyright © 2017 Lackie, Maciejewski, Ostapchenko, Marques-Lopes, Choy, Duennwald, Prado and Prado. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Lackie, Rachel E.
Maciejewski, Andrzej
Ostapchenko, Valeriy G.
Marques-Lopes, Jose
Choy, Wing-Yiu
Duennwald, Martin L.
Prado, Vania F.
Prado, Marco A. M.
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
title The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
title_full The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
title_fullStr The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
title_full_unstemmed The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
title_short The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
title_sort hsp70/hsp90 chaperone machinery in neurodegenerative diseases
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433227/
https://www.ncbi.nlm.nih.gov/pubmed/28559789
http://dx.doi.org/10.3389/fnins.2017.00254
work_keys_str_mv AT lackierachele thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT maciejewskiandrzej thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT ostapchenkovaleriyg thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT marqueslopesjose thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT choywingyiu thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT duennwaldmartinl thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT pradovaniaf thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT pradomarcoam thehsp70hsp90chaperonemachineryinneurodegenerativediseases
AT lackierachele hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT maciejewskiandrzej hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT ostapchenkovaleriyg hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT marqueslopesjose hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT choywingyiu hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT duennwaldmartinl hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT pradovaniaf hsp70hsp90chaperonemachineryinneurodegenerativediseases
AT pradomarcoam hsp70hsp90chaperonemachineryinneurodegenerativediseases